Innovative Therapeutic
Devices Addressing
Significant Unmet Needs

Latest News


Fibralign Announces CE Mark Approval for BioBridge®

Fibralign Announces CE Mark Approval for BioBridge®

European approval for novel device supporting surgical treatment of lymphedema September 14, 2020 (Union City, CA) – Fibralign Corp., a Stanford spin-out and developer of therapeutic biomedical devices, today announced that it has received CE mark for its first...

read more
Fibralign Announces Strategic Partnership with Terumo

Fibralign Announces Strategic Partnership with Terumo

Exclusive agreement for Terumo to market and distribute Fibralign’s BioBridge in Japan June 02, 2020 06:00 AM Eastern Daylight Time UNION CITY, Calif.--(BUSINESS WIRE)--Fibralign Corp., a Stanford spin-out developer of therapeutic biomedical devices, has announced...

read more

* BioBridge has not been approved by the FDA for treating secondary lymphedema.

About Us

Fibralign is an award-winning, Stanford-spinout company that produces novel therapeutic biomedical devices that are designed to address major unmet medical needs.
The company has launched its first product, the BioBridge® Collagen Matrix, which has been developed to address secondary lymphedema*, a global chronic disease that currently has no cure.

BioBridge® Collagen Matrix

  • Novel thread-like nanostructured surgical mesh for use in soft tissue repair
  • Clinical benefit demonstrated in treating secondary lymphedema*
  • CE mark approved, Class III device
  • FDA 510(k) cleared device*
  • Commercially available now in the US and Europe

Nanoweave® Technology

Fibralign is developing a pipeline of compelling novel products which are based on its proprietary Nanoweave® scaffolding platform that can be tailored to address a wide range of high-value applications. Nanoweave technology provides the means to precisely print 3D scaffolding in such a way that mimics human tissue nano structure and directly influence the body’s repair function.

Grants, Awards, Partners and Collaborators

Fibralign has been recognized for its vision and potential to impact lives globally. We are supported in our mission by world class partners and collaborators.